Search research articles
Contact Us
Filters
Showing results (1-10 of 8) with videos related to
Page
of 1
Sort By:
Open Forum Infectious Diseases
|
March 9, 2026
Successful Control of Refractory <i>Coccidioides</i> Meningitis With MAT2203
Sanjay R Mehta, Scott Johns, Theresa Matkovits, et al.
Journal of Medical Virology
|
December 13, 2016
FV-100 versus valacyclovir for the prevention of post-herpetic neuralgia and the treatment of acute herpes zoster-associated pain: A randomized-controlled trial
Stephen K Tyring, Patricia Lee, Gordon T Hill, et al.
Biorxiv : the Preprint Server for Biology
|
December 4, 2023
Efficacy of an oral lipid nanocrystal (LNC) formulation of amphotericin B (MAT2203) in the neutropenic mouse model of pulmonary mucormycosis
Yiyou Gu, Teclegiorgis Gebremariam, Sondus Alkhazraji, et al.
Antimicrobial Agents and Chemotherapy
|
April 30, 2024
Efficacy of an oral lipid nanocrystal formulation of amphotericin B (MAT2203) in the neutropenic mouse model of pulmonary mucormycosis
Yiyou Gu, Teclegiorgis Gebremariam, Sondus Alkhazraji, et al.
Open Forum Infectious Diseases
|
August 2, 2024
Successful Treatment of Refractory Cutaneous Protothecosis With MAT2203, an Oral Lipid Nanocrystal Formulation of Amphotericin B
Joseph Pechacek, Monica M Schmitt, Elise M N Ferrè, et al.
Antimicrobial Agents and Chemotherapy
|
August 5, 2020
Phase I EnACT Trial of the Safety and Tolerability of a Novel Oral Formulation of Amphotericin B
Caleb P Skipper, Mucunguzi Atukunda, Anna Stadelman, et al.
Antimicrobial Agents and Chemotherapy
|
June 14, 2022
Efficacy of Cochleated Amphotericin B in Mouse and Human Mucocutaneous Candidiasis
Jigar V Desai, Amanda Urban, Doris Z Swaim, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 22, 2023
Oral Lipid Nanocrystal Amphotericin B for Cryptococcal Meningitis: A Randomized Clinical Trial
David R Boulware, Mucunguzi Atukunda, Enock Kagimu, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 8) with videos related to
Sort By:
Page
of 1
Open Forum Infectious Diseases
|
March 9, 2026
Successful Control of Refractory <i>Coccidioides</i> Meningitis With MAT2203
Sanjay R Mehta, Scott Johns, Theresa Matkovits, et al.
Journal of Medical Virology
|
December 13, 2016
FV-100 versus valacyclovir for the prevention of post-herpetic neuralgia and the treatment of acute herpes zoster-associated pain: A randomized-controlled trial
Stephen K Tyring, Patricia Lee, Gordon T Hill, et al.
Biorxiv : the Preprint Server for Biology
|
December 4, 2023
Efficacy of an oral lipid nanocrystal (LNC) formulation of amphotericin B (MAT2203) in the neutropenic mouse model of pulmonary mucormycosis
Yiyou Gu, Teclegiorgis Gebremariam, Sondus Alkhazraji, et al.
Antimicrobial Agents and Chemotherapy
|
April 30, 2024
Efficacy of an oral lipid nanocrystal formulation of amphotericin B (MAT2203) in the neutropenic mouse model of pulmonary mucormycosis
Yiyou Gu, Teclegiorgis Gebremariam, Sondus Alkhazraji, et al.
Open Forum Infectious Diseases
|
August 2, 2024
Successful Treatment of Refractory Cutaneous Protothecosis With MAT2203, an Oral Lipid Nanocrystal Formulation of Amphotericin B
Joseph Pechacek, Monica M Schmitt, Elise M N Ferrè, et al.
Antimicrobial Agents and Chemotherapy
|
August 5, 2020
Phase I EnACT Trial of the Safety and Tolerability of a Novel Oral Formulation of Amphotericin B
Caleb P Skipper, Mucunguzi Atukunda, Anna Stadelman, et al.
Antimicrobial Agents and Chemotherapy
|
June 14, 2022
Efficacy of Cochleated Amphotericin B in Mouse and Human Mucocutaneous Candidiasis
Jigar V Desai, Amanda Urban, Doris Z Swaim, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 22, 2023
Oral Lipid Nanocrystal Amphotericin B for Cryptococcal Meningitis: A Randomized Clinical Trial
David R Boulware, Mucunguzi Atukunda, Enock Kagimu, et al.
Page
of 1